Paritaprevir is an antiviral medication used primarily in the treatment of hepatitis Cvirus (HCV) infection. It is a direct-acting antiviral (DAA) that acts asaprotease inhibitor, specifically targeting the NS3/4A proteaseenzyme, which is crucial for the replication of the hepatitis Cvirus.
